Van Well Daan sold $10K of SOPH
Van Well Daan (Chief Legal Officer) sold 1,411 shares of SOPHiA GENETICS SA (SOPH) at $7.44 on 2026-11-09 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and unlikely to affect SOPHiA GENETICS' valuation materially.
Market read
A small insider sell filing with limited trading relevance.
What to watch
Potential tax planning or liquidity needs could be driving the sale, not company fundamentals.
Background
Form 4 filings disclose insider transactions and are used by investors to gauge insider sentiment.
Ticker impact
Chief Legal Officer sold 1,411 shares for $10,491, a Form 4 filing disclosing a small insider sale.
likely slight downward pressure as market prices in the insider sale
The sale is small ($10k) and unlikely to move the stock significantly, but it signals a modest reduction in insider holdings.
Market effects
No material impact on the broader biotech sector.
Limited to the company's share price.
None
Counterpoint
The sale may be routine and not indicative of any negative outlook.
Key entities
- CompanySOPHiA GENETICS SA
Swiss biotech firm listed on NASDAQ under SOPH.
- PersonVan Well Daan
Chief Legal Officer of SOPHiA GENETICS, reporting the insider sale.



